Literature DB >> 19620011

Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.

Pierfausto Seneci1, Aldo Bianchi, Cristina Battaglia, Laura Belvisi, Martino Bolognesi, Andrea Caprini, Federica Cossu, Elena de Franco, Marilenia de Matteo, Domenico Delia, Carmelo Drago, Amira Khaled, Daniele Lecis, Leonardo Manzoni, Moira Marizzoni, Eloise Mastrangelo, Mario Milani, Ilaria Motto, Elisabetta Moroni, Donatella Potenza, Vincenzo Rizzo, Federica Servida, Elisa Turlizzi, Maurizio Varrone, Francesca Vasile, Carlo Scolastico.   

Abstract

Novel proapoptotic Smac mimics/IAPs inhibitors have been designed, synthesized and characterized. Computational models and structural studies (crystallography, NMR) have elucidated the SAR of this class of inhibitors, and have permitted further optimization of their properties. In vitro characterization (XIAP BIR3 and linker-BIR2-BIR3 binding, cytotox assays, early ADMET profiling) of the compounds has been performed, identifying one lead for further in vitro and in vivo evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620011     DOI: 10.1016/j.bmc.2009.07.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells.

Authors:  Viralkumar Patel; Kumudha Balakrishnan; Michael J Keating; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2014-12-23       Impact factor: 22.113

2.  Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.

Authors:  Federica Servida; Daniele Lecis; Cinzia Scavullo; Carmelo Drago; Pierfausto Seneci; Carmelo Carlo-Stella; Leonardo Manzoni; Elio Polli; Giorgio Lambertenghi Deliliers; Domenico Delia; Francesco Onida
Journal:  Invest New Drugs       Date:  2010-07-08       Impact factor: 3.850

3.  Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.

Authors:  Federica Cossu; Francesca Malvezzi; Giulia Canevari; Eloise Mastrangelo; Daniele Lecis; Domenico Delia; Pierfausto Seneci; Carlo Scolastico; Martino Bolognesi; Mario Milani
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

4.  Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.

Authors:  D Lecis; C Drago; L Manzoni; P Seneci; C Scolastico; E Mastrangelo; M Bolognesi; A Anichini; H Kashkar; H Walczak; D Delia
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

5.  Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.

Authors:  Federica Cossu; Mario Milani; Patrice Vachette; Francesca Malvezzi; Serena Grassi; Daniele Lecis; Domenico Delia; Carmelo Drago; Pierfausto Seneci; Martino Bolognesi; Eloise Mastrangelo
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

6.  Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Authors:  D Lattuada; R Gualtierotti; K Crotta; P Seneci; F Ingegnoli; C Corradini; R Viganò; O Marelli; C Casnici
Journal:  Mediators Inflamm       Date:  2016-02-17       Impact factor: 4.711

Review 7.  Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.

Authors:  Darren Finlay; Peter Teriete; Mitchell Vamos; Nicholas D P Cosford; Kristiina Vuori
Journal:  F1000Res       Date:  2017-04-27

8.  Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.

Authors:  D Lecis; M De Cesare; P Perego; A Conti; E Corna; C Drago; P Seneci; H Walczak; M P Colombo; D Delia; S Sangaletti
Journal:  Cell Death Dis       Date:  2013-11-14       Impact factor: 8.469

9.  Proapoptotic activity of a monomeric smac mimetic on human fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  D Lattuada; C Casnici; K Crotta; P F Seneci; C Corradini; M Truzzi; F Ingegnoli; O Marelli
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

10.  Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic.

Authors:  Kumudha Balakrishnan; Min Fu; Francesco Onida; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.